In:
Pediatric Blood & Cancer, Wiley, Vol. 61, No. 1 ( 2014-01), p. 165-170
Abstract:
The Psychosocial Screening Tool (PAT) was developed and validated with a sample of caregivers of children newly diagnosed with cancer in the United States. This study aimed to assess cultural adaptation (Phase 1) and validity and reliability of the revised PAT (PATrev) with a Canadian sample (Phase 2). Procedure In Phase 1, a convenience sample of seven parents of children who were treated for cancer and six pediatric oncology healthcare experts participated. In Phase 2, 67 parents of children newly diagnosed with cancer from 4 Canadian pediatric cancer centers participated. To assess reliability and validity of the PATrev, parents completed behavioral (BASC‐2) and quality of life (PedsQL) instruments about the child and an anxiety inventory (STAI) about themselves. Results The PAT required minor changes to be culturally adapted for the Canadian population. The PATrev had strong inter‐rater (0.77) test–retest (0.75), and internal consistency reliability (0.85), as well as moderate to strong validity comparing PATrev child's problems and PedsQL total (−0.49), PedsQL anxiety (−0.47), BASC‐2 internalizing (0.64), behavioral (0.63), and adaptive scores (−0.56). PATrev discriminative validity was confirmed with BASC‐2 scores (AUR scores of 0.70–0.74). PATrev parental stressors were strongly correlated to STAI scores (0.53). Finally, agreement between PATrev child's problems and parental anxiety scores was moderate (0.47). Conclusion This study supports the original PAT, demonstrates PATrev is a reliable and valid psychosocial screening tool, and provides unique evidence regarding early psychosocial risk in the family, which have important implications for guiding psychosocial practice. Pediatr Blood Cancer 2014;61:165–170. © 2013 Wiley Periodicals, Inc.
Type of Medium:
Online Resource
ISSN:
1545-5009
,
1545-5017
Language:
English
Publisher:
Wiley
Publication Date:
2014
detail.hit.zdb_id:
2130978-4
